226
Views
34
CrossRef citations to date
0
Altmetric
Original Research

Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models

, , , , , , , & show all
Pages 161-180 | Published online: 21 Dec 2018

References

  • WeirHKAndersonRNColeman KingSMHeart Disease and Cancer Deaths – Trends and Projections in the United States, 1969–2020Prev Chronic Dis201613E15727854420
  • FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
  • MctiernanABehavioral risk factors in breast cancer: can risk be modified?Oncologist20038432633412897329
  • CardosoFCostaASenkusE3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)Ann Oncol201728123111313328327998
  • CardosoFCostaASenkusE3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)Breast20173124425927927580
  • SinglaAKGargAAggarwalDPaclitaxel and its formulationsInt J Pharm20022351–217919211879753
  • ShapiroCLRechtASide effects of adjuvant treatment of breast cancerN Engl J Med2001344261997200811430330
  • LyerSSinghRTietzeRAlexiouCMagnetic nanoparticles for magnetic drug targetingBiomed Tech2015605465475
  • TietzeRZalogaJUnterwegerHMagnetic nanoparticle-based drug delivery for cancer therapyBiochem Biophys Res Commun2015468346347026271592
  • TietzeRRahnHLyerSVisualization of superparamagnetic nanoparticles in vascular tissue using XµCT and histologyHistochem Cell Biol2011135215315821279377
  • JankoCDürrSMunozLEMagnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytesInt J Mol Sci20131447341735523549268
  • TietzeRLyerSDürrSEfficient drug-delivery using magnetic nanoparticles – biodistribution and therapeutic effects in tumour bearing rabbitsNanomedicine20139796197123669367
  • AlevMEgenbergerLMühleisenLTargeting of drug-loaded nanoparticles to tumor sites increases cell death and release of danger signalsJ Control Release2018285678030008372
  • DürrSJankoCLyerSMagnetic nanoparticles for cancer therapyNanotechnol Rev201324395
  • JiangGZhangSYazdanparastAComprehensive comparison of molecular portraits between cell lines and tumors in breast cancerBMC Genomics201617Suppl 752527556158
  • ChekhunSBezdenezhnykhNShvetsJLukianovaNExpression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtypeExp Oncol201335317417924084454
  • ZalogaJPöttlerMLeitingerGPharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targetingEur J Pharm Biopharm201610115216226854862
  • BicaDVékásLAvdeevMVSterically stabilized water based magnetic fluids: synthesis, structure and propertiesJ Magn Magn Mater200731111721
  • ZalogaJStapfMNowakJTangential Flow Ultrafiltration Allows Purification and Concentration of Lauric Acid-/Albumin-Coated Particles for Improved Magnetic TreatmentInt J Mol Sci2015168192911930726287178
  • ZalogaJJankoCAgarwalRDifferent storage conditions influence biocompatibility and physicochemical properties of iron oxide nanoparticlesInt J Mol Sci20151659368938425918940
  • PollerJMZalogaJSchreiberESelection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptakeInt J Nanomedicine2017123207322028458541
  • MühlbergerMJankoCUnterwegerHFunctionalization of T lymphocytes for magnetically controlled immune therapy: selection of suitable superparamagnetic iron oxide nanoparticlesJ Magn Magn Mater20194736167
  • MunozLEMaueröderCChaurioRBerensCHerrmannMJankoCColourful death: six-parameter classification of cell death by flow cytometry-dead cells tell talesAutoimmunity201346533634123231469
  • FriedrichRPJankoCPoettlerMFlow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methodsInt J Nanomedicine2015104185420126170658
  • RiccardiCNicolettiIAnalysis of apoptosis by propidium iodide staining and flow cytometryNat Protoc2006131458146117406435
  • GradisharWJAlbumin-bound paclitaxel: a next-generation taxaneExpert Opin Pharmacother2006781041105316722814
  • CurrySMandelkowHBrickPFranksNCrystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sitesNat Struct Biol1998598278359731778
  • CalatayudMPSanzBRaffaVRiggioCIbarraMRGoyaGFThe effect of surface charge of functionalized Fe3O4 nanoparticles on protein adsorption and cell uptakeBiomaterials201435246389639924816288
  • TenzerSDocterDKuharevJRapid formation of plasma protein corona critically affects nanoparticle pathophysiologyNat Nanotechnol201381077278124056901
  • Malvern InstrumentsDynamic Light Scattering: An Introduction in 30 Minutes. Technical NoteMalvernMalvern Instruments2012
  • PaálKMüllerJHegedûsLHigh affinity binding of paclitaxel to human serum albuminEur J Biochem200126872187219111277943
  • BrabersVAMProgress in Spinel Ferrite Research Handbook of Magnetic Materials 8Amsterdam, Lausanne, New York, Oxford, TokyoElsevier1995199344
  • LudwigFBalcerisCJonassonCJohanssonCAnalysis of AC Susceptibility Spectra for the Characterization of Magnetic NanoparticlesIEEE Trans Magn2017531114
  • AntipasGSStatharasETserotasPPapadopoulosNHristoforouEExperimental and first-principles characterization of functionalized magnetic nanoparticlesChemphyschem20131491934194223649714
  • YangHYangSKongJDongAYuSObtaining information about protein secondary structures in aqueous solution using Fourier transform IR spectroscopyNat Protoc201510338239625654756
  • HuangYTLiaoHFWangSLLinSYGlycation and secondary conformational changes of human serum albumin: study of the FTIR spectroscopic curve-fitting techniqueAIMS Biophys201632247260
  • PratAPerouCMDeconstructing the molecular portraits of breast cancerMol Oncol20115152321147047
  • NeveRMChinKFridlyandJA collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell200610651552717157791
  • AlmutaryASandersonBJThe MTT and Crystal Violet Assays: Potential Confounders in Nanoparticle Toxicity TestingInt J Toxicol201635445446227207930
  • KumarGDegheidyHCaseyBJGoeringPLFlow cytometry evaluation of in vitro cellular necrosis and apoptosis induced by silver nanoparticlesFood Chem Toxicol201585455126115599
  • JankoCMunozLChaurioRNavigation to the graveyard-induction of various pathways of necrosis and their classification by flow cytometryMethods Mol Biol2013100431523733565
  • LiebmannJECookJALipschultzCTeagueDFisherJMitchellJBCytotoxic studies of paclitaxel (Taxol) in human tumour cell linesBr J Cancer1993686110411097903152
  • HirschhaeuserFMenneHDittfeldCWestJMueller-KlieserWKunz-SchughartLAMulticellular tumor spheroids: an underestimated tool is catching up againJ Biotechnol2010148131520097238
  • GriffithLGSwartzMACapturing complex 3D tissue physiology in vitroNat Rev Mol Cell Biol20067321122416496023
  • HornungAPoettlerMFriedrichRPTreatment efficiency of free and nanoparticle-loaded mitoxantrone for magnetic drug targeting in multicellular tumor spheroidsMolecules20152010180161803026437393
  • HornungAPoettlerMFriedrichRPToxicity of Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles in a HT-29 tumour spheroid modelAnticancer Res20163663093310127272833
  • HaqueRAhmedSAInzhakovaGImpact of breast cancer subtypes and treatment on survival: an analysis spanning two decadesCancer Epidemiol Biomarkers Prev201221101848185522989461
  • BeenkenSWBlandKIBiomarkers for breast cancerMinerva Chir200257443744812145573